Dylan Weil

Dylan is a senior scientist within the Bioassay, Biosafety, and Impurities group at AstraZeneca. He specializes in the development, qualification, and implementation of potency assays for use in clinical-stage drug development, characterization, and GMP testing across a broad range of biologics modalities. He holds a B.S. in Molecular Bioscience & Biotechnology from the Rochester Institute of Technology, and an M.S. in Biotechnology, with a focus in Bioinformatics, from Johns Hopkins University.